Sellas Life Sciences Stock Alpha and Beta Analysis

SLS Stock  USD 3.77  0.46  13.90%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Sellas Life Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Sellas Life over a specified time horizon. Remember, high Sellas Life's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Sellas Life's market risk premium analysis include:
Beta
0.46
Alpha
1.18
Risk
5.71
Sharpe Ratio
0.23
Expected Return
1.29
Please note that although Sellas Life alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Sellas Life did 1.18  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Sellas Life Sciences stock's relative risk over its benchmark. Sellas Life Sciences has a beta of 0.46  . As returns on the market increase, Sellas Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sellas Life is expected to be smaller as well. Book Value Per Share is expected to decline to 0.01 this year. Tangible Book Value Per Share is expected to decline to 0.01 this year.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Sellas Life Backtesting, Sellas Life Valuation, Sellas Life Correlation, Sellas Life Hype Analysis, Sellas Life Volatility, Sellas Life History and analyze Sellas Life Performance.

Sellas Life Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Sellas Life market risk premium is the additional return an investor will receive from holding Sellas Life long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sellas Life. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Sellas Life's performance over market.
α1.18   β0.46

Sellas Life expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Sellas Life's Buy-and-hold return. Our buy-and-hold chart shows how Sellas Life performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Sellas Life Market Price Analysis

Market price analysis indicators help investors to evaluate how Sellas Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sellas Life shares will generate the highest return on investment. By understating and applying Sellas Life stock market price indicators, traders can identify Sellas Life position entry and exit signals to maximize returns.

Sellas Life Return and Market Media

The median price of Sellas Life for the period between Fri, Oct 3, 2025 and Thu, Jan 1, 2026 is 1.9 with a coefficient of variation of 22.31. The daily time series for the period is distributed with a sample standard deviation of 0.42, arithmetic mean of 1.9, and mean deviation of 0.3. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum
10/22/2025
2
Papa Johns Is Not First Here Are 3 Other Stocks Rocked By Market-Moving Fake News
11/11/2025
3
SELLAS Life Sciences Group Inc. stock prediction for this week - Weekly Trade Report Low Risk Entry Point Guides - newser.com
11/14/2025
4
Disposition of 187066 shares by Stergiou Angelos M. of Sellas Life at 1.5 subject to Rule 16b-3
12/03/2025
5
Monster Energys Rayssa Leal Takes First Place in Womens Street Skateboarding at 2025 SLS Super Crown World Championships
12/08/2025
6
SELLAS Life Sciences Is Up 15.5 percent After Encouraging Phase 2 Data In High-Risk AML
12/12/2025
7
SELLAS Life Sciences Group, Inc. Stock Opinions on Clinical Trial Results - Quiver Quantitative
12/23/2025
8
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S in Acute Myeloid Leukemia
12/29/2025

About Sellas Life Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Sellas or other stocks. Alpha measures the amount that position in Sellas Life Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Dividend Yield0.0038690.003675
Price To Sales Ratio52.6450.01

Sellas Life Upcoming Company Events

As portrayed in its financial statements, the presentation of Sellas Life's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sellas Life's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Sellas Life's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Sellas Life. Please utilize our Beneish M Score to check the likelihood of Sellas Life's management manipulating its earnings.
21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Sellas Life

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.